Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Robert Barrow
Recent news which mentions Robert Barrow
MindMed Calls FDA Experts To Validate LSD Drug Development Strategy
May 25, 2023
Tickers
MNMD
Tags
Psychedelic/Assisted Therapies
Benzinga
Robert Barrow
From
Benzinga
MindMed's Q3 2022 Financials & Business, Setting The Stage For Phase 3 Trials
November 11, 2022
Tickers
MNMD
Tags
Market News
Cannabis
Penny Stocks
From
Benzinga
MindMed's First Patient Dosing Clinical Trial With LSD For Treatment Of Generalized Anxiety Disorder
August 25, 2022
Tickers
MNMD
Tags
MNMD
MindMed
News
From
Benzinga
MindMed: Financial And Business Results For Q2 2022, Management And Pipeline Changes
August 12, 2022
Tickers
MNMD
OPNT
Tags
Tiaki Therapeutics
Earnings
Dr/ Roger Crystal
From
Benzinga
Cannabis Movers & Shakers: Mind Medicine, 22nd Century Group, Grown Rogue International
May 24, 2022
Tickers
GRUSF
HALO
MNMD
XXII
Tags
Benzinga
Movers & Shakers
John J/ Miller
From
Benzinga
MindMed Appoints Schond L. Greenway As CFO
May 23, 2022
Tickers
AVTX
HALO
MEOBF
MNMD
Tags
Schond L/ Greenway
Psychedelics
HALO
From
Benzinga
From Pharma To Psychedelics, Robert Barrow, CEO Of MindMed: Meet Our Speakers
April 04, 2022
Tickers
MNMD
Tags
Market News
J/R/ Rahn
Cannabis
From
Benzinga
MindMed Converts Shares To Have A Single Class
February 23, 2022
Tickers
MNMD
Tags
MNMD
News
Robert Barrow
From
Benzinga
Cybin, MindMed, And Field Trip Health Headline PSYC's First CEO Round Table Event
February 14, 2022
Tickers
CYBN
FTRP
MMDCF
PSYC
Tags
Ronan Levy
PSYC
Kevin O’Leary
From
Benzinga
MindMed Shares Soar After FDA Approves First Commercial Clinical Trial On LSD In 40 Years
January 26, 2022
Tickers
MNMD
Tags
Markets
Topics
FDA
From
Benzinga
Cannabis Movers & Shakers: MindMed, Halo Collective, Item 9, PSYC, Flora Growth
January 10, 2022
Tickers
AMZN
CXXIF
FLGC
HCANF
Tags
PSYC
New Frontier Data
Markets
From
Benzinga
MindMed Completes Phase 1 Clinical Trial Of Non-Hallucinogenic Proprietary Derivative Of Ibogaine
January 04, 2022
Tickers
MNMD
Tags
Benzinga
Robert Barrow
MNMD
From
Benzinga
Cannabis Movers & Shakers: MindMed & Trulieve Management Shake-Ups, Credex Corp & CapStone Bolster Leadership Teams
December 29, 2021
Tickers
CRDX
CURLF
MNMD
TCNNF
Tags
Ilera Healthcare
Markets
Benzinga
From
Benzinga
MindMed Shares Update On Phase 2b Trials of LSD For Treating Generalized Anxiety Disorder
December 22, 2021
Tickers
MNMD
Tags
News
MNMD
MindMed
From
Benzinga
MindMed Advances Phase 2a LSD Microdose Trial For Adult ADHD
December 17, 2021
Tickers
MNMD
Tags
Benzinga
Robert Barrow
Matthias Liechti
From
Benzinga
MindMed Names Robert Barrow As CEO & Director, Announces Management Shake-Ups
December 14, 2021
Tickers
CRLBF
MNMD
Tags
CRLBF
Market News
Cannabis
From
Benzinga
EXCLUSIVE: MindMed CEO Rob Barrow On Growth Aspirations, Development Pipeline
December 10, 2021
Tickers
MNMD
NDAQ
Tags
NDAQ
Benzinga
Robert Barrow
From
Benzinga
Cannabis Movers & Shakers: Mind Medicine, Avant Brands, Delic, Agrify, Ascend Wellness, Pure Beauty
November 11, 2021
Tickers
AAWH
MMNFF
MNMD
Tags
AAWH
Raymond Chang
MMNFF
From
Benzinga
Cannabis Movers & Shakers: Leafly Holdings, Linneo Health, Flowhub, MindMed
October 04, 2021
Tickers
BAC
CGC
CRARF
CS
Tags
Markets
cannabis appointemnts
Movers & Shakers
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.